| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/30/2011 | EP2302039A1 Virus-like particles comprising HML-2 gag polypeptide |
| 03/30/2011 | EP2302033A2 Identification of virulence associated regions RD1 and RD5 enabling the development of improved vaccines of M. bovis BCG and M. microti |
| 03/30/2011 | EP2302031A1 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms |
| 03/30/2011 | EP2302028A1 Sequencer |
| 03/30/2011 | EP2302027A2 Alpha-amylase mutants |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301968A2 Humanized monoclonal antibody HPAM4 |
| 03/30/2011 | EP2301967A2 Single domain antibodies for nasal administration |
| 03/30/2011 | EP2301966A1 Immunoglobulin variants and uses thereof |
| 03/30/2011 | EP2301964A1 High affinity HIV T cell receptors |
| 03/30/2011 | EP2301960A2 Polymer conjugates of mutated neublastin |
| 03/30/2011 | EP2301959A2 Motif-grafted hybrid polypeptides and uses thereof |
| 03/30/2011 | EP2301958A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 03/30/2011 | EP2301949A1 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 03/30/2011 | EP2301948A1 Promoters for regulation of gene expression in plant roots |
| 03/30/2011 | EP2301946A1 Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid |
| 03/30/2011 | EP2301629A2 Anti-interferon-alpha antibodies |
| 03/30/2011 | EP2301586A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 03/30/2011 | EP2301585A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 03/30/2011 | EP2301584A1 Methods and compositions for treatment of interferon-resistant tumors |
| 03/30/2011 | EP2301583A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 03/30/2011 | EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/30/2011 | EP2301581A1 Production and use of novel peptide-based agents for use with B1-specific antibodies |
| 03/30/2011 | EP2301580A1 Anti-VEGF antibodies |
| 03/30/2011 | EP2301578A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301577A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301573A1 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 03/30/2011 | EP2301563A2 HSP20 peptides |
| 03/30/2011 | EP2301560A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue |
| 03/30/2011 | EP2301559A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 03/30/2011 | EP2301553A1 Polynucleotide therapy |
| 03/30/2011 | EP2301552A1 Polynucleotide therapy |
| 03/30/2011 | EP2300618A1 Bollworm insect resistance management in transgenic plants |
| 03/30/2011 | EP2300617A1 Methods and vectors for producing transgenic plants |
| 03/30/2011 | EP2300616A1 Selection method ii |
| 03/30/2011 | EP2300615A2 Pichia pastoris das promoter variants |
| 03/30/2011 | EP2300614A2 Methods and compositions for treatment of mitochondrial disorders |
| 03/30/2011 | EP2300613A2 Mutated and chemically modified thermally stable dna polymerases |
| 03/30/2011 | EP2300612A2 Modulation of gm98 (mrf) in remyelination |
| 03/30/2011 | EP2300611A2 Programming and reprogramming of cells |
| 03/30/2011 | EP2300610A1 Novel bmp-12-related proteins and methods of their manufacture |
| 03/30/2011 | EP2300609A1 Novel immunoadjuvant flagellin-based compounds and use thereof |
| 03/30/2011 | EP2300608A2 Methods to treat solid tumors |
| 03/30/2011 | EP2300607A2 Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells |
| 03/30/2011 | EP2300500A1 Anti-flt3 antibodies |
| 03/30/2011 | EP2300499A1 Anti-prion protein antibody fragment |
| 03/30/2011 | EP2300492A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 03/30/2011 | EP2300488A1 Cell lysis reagent for isolation of rna |
| 03/30/2011 | EP2300051A1 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
| 03/30/2011 | EP2300039A2 ANXIOLYTIC COMPOSITION CONTAINING ALPHAs¹-CASEIN -DERIVED PEPTIDES |
| 03/30/2011 | EP2300023A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
| 03/30/2011 | EP2300019A2 Antisense formulation |
| 03/30/2011 | EP2299804A2 Constructs for expressing herbicide tolerance genes, related plants, and related trait combinations |
| 03/30/2011 | EP2121736B1 New anti-malaria vaccine compositions and uses thereof |
| 03/30/2011 | EP2076601B1 High yield production of sialic acid (neu5ac) by fermentation |
| 03/30/2011 | EP1838858B1 Genes conferring herbicide resistance |
| 03/30/2011 | EP1812459B1 Method for the mass production of multimeric mannose binding lectin |
| 03/30/2011 | EP1799814B1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 03/30/2011 | EP1737965B1 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants |
| 03/30/2011 | EP1687417B9 Plants with reduced activity of a class 3 branching enzyme |
| 03/30/2011 | EP1680508B1 Site-specific intestinal delivery and/or production of biologically active substances |
| 03/30/2011 | EP1670932B1 Libraries of recombinant chimeric proteins |
| 03/30/2011 | EP1652852B1 Nucleoside capable of releasing functional unit through oxidation and process for producing oligonucleotide containing the same |
| 03/30/2011 | EP1577390B9 Human cancer-related genes, the products encoded thereby and applications thereof |
| 03/30/2011 | EP1500698B1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 03/30/2011 | EP1458888B1 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene |
| 03/30/2011 | EP1394261B1 Antigens for immunisation |
| 03/30/2011 | EP1337242B1 Gene delivery formulations for treatment of ischemic conditions |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | EP1294930B1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/30/2011 | EP1220949B1 Chromosome-wide analysis of protein-dna interactions |
| 03/30/2011 | EP1196196B8 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 03/30/2011 | EP1053023B2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 03/30/2011 | CN1956995B Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 03/30/2011 | CN1950520B Method and assembly for DNA isolation with dry reagents |
| 03/30/2011 | CN1912125B Stress-inducing promoter derived from rice |
| 03/30/2011 | CN1891823B CETP gene with specific mononucleotide pleiomorphism, and its detecting method and use |
| 03/30/2011 | CN1863918B Packaging cells for recombinant adenovirus |
| 03/30/2011 | CN1780855B Human il-1 beta antagonists |
| 03/30/2011 | CN1728937B Temporal seed promoters for expressing genes in plants |
| 03/30/2011 | CN1717418B Antibody for the thyrotropin receptor and uses thereof |
| 03/30/2011 | CN1602351B Islet cells from human embryonic stem cells |
| 03/30/2011 | CN101999002A Methods of diagnosing and treating PARP-mediated diseases |
| 03/30/2011 | CN101998994A Zea mays aba signaling genes and methods of use |
| 03/30/2011 | CN101998993A New mutated hydroxyphenylpyruvate dioxygenase, DNA sequence and isolation of plants which are tolerant to hppd inhibitor herbicides |
| 03/30/2011 | CN101998992A Methods involving MS4A12 and agents targeting MS4A12 for therapy, diagnosis and testing |
| 03/30/2011 | CN101998991A Methods and devices for producing biomolecules |
| 03/30/2011 | CN101998988A Cytochrome P450 genes conferring herbicide resistance |
| 03/30/2011 | CN101998987A Commensal bacteria as signal mediators within a mammalian host |
| 03/30/2011 | CN101998965A Immunosuppressive polypeptides and nucleic acid |
| 03/30/2011 | CN101995468A Time resolution immunoassay test kit and method of ciprofloxacin residual |
| 03/30/2011 | CN101995460A Ractopamine residual time resolution immunoassay kit and detection method thereof |
| 03/30/2011 | CN101993952A Mutation screening probe of SLC25A13 gene and application thereof |
| 03/30/2011 | CN101993907A Transgenic plants expressing CIVPS or intein modified proteins and related method |
| 03/30/2011 | CN101993906A Transgenic plants expressing CIVPS or intein modified proteins and related method |
| 03/30/2011 | CN101993904A Method for producing 5'-guanylic acid |
| 03/30/2011 | CN101993895A Construction and application method of efficient double promoter PLEGFP-N1-spMyoD1 green fluorescence retrovirus vector |
| 03/30/2011 | CN101993894A Construction method of siRNA adenovirus carrier for restraining rat IL-1beta gene expression |
| 03/30/2011 | CN101993893A Construction method of HBV (Hepatitis B Virus) isolating strain replicating-form plasmid |
| 03/30/2011 | CN101993892A Eukaryotic expression vector for expressing shRNA (short hairpin Ribonucleic Acid) in manner of targeting in cancer cells |